| Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer (NCT00010244) | UNICANCER | 1999-09-01 |
| Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer (NCT00004071) | Pfizer | 1999-08-01 |
| Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer (NCT00003903) | University of Rochester | 1999-07-01 |
| Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer (NCT00004065) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer (NCT00004211) | Duke University | 1999-07-01 |
| Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer (NCT00005075) | EDAP Technomed | 1999-07-01 |
| Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence (NCT00003645) | M.D. Anderson Cancer Center | 1999-06-14 |
| Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer (NCT00004050) | Vical | 1999-06-01 |
| Chemotherapy in Treating Patients With Prostate Cancer (NCT00004045) | Daiichi Sankyo | 1999-06-01 |
| Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer (NCT00005632) | Memorial Sloan Kettering Cancer Center | 1999-06-01 |
| Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00010231) | University of Pittsburgh | 1999-06-01 |
| Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®) (NCT00140387) | Cell Genesys | 1999-05-01 |
| Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00006114) | GERCOR - Multidisciplinary Oncology Cooperative Group | 1999-05-01 |
| Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer (NCT00140400) | Cell Genesys | 1999-05-01 |
| Microarray Analysis of Gene Expression in Prostate Tissues (NCT00186368) | Stanford University | 1999-04-06 |
| Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA) (NCT00678054) | University of California, San Francisco | 1999-04-01 |
| Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate (NCT03034187) | University Medical Center Groningen | 1999-04-01 |
| Liposomal Doxorubicin in Treating Patients With Prostate Cancer (NCT00004014) | Case Comprehensive Cancer Center | 1999-04-01 |
| Study Evaluating the Safety and Tolerability of L-377202 (NCT00987753) | University of Alabama at Birmingham | 1999-03-01 |
| Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00005627) | Dana-Farber Cancer Institute | 1999-03-01 |
| Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer (NCT00003614) | Eastern Cooperative Oncology Group | 1999-02-04 |
| Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer (NCT00004043) | OHSU Knight Cancer Institute | 1999-02-01 |
| Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer (NCT00003653) | NCIC Clinical Trials Group | 1999-01-05 |
| High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer (NCT00494546) | VA Puget Sound Health Care System | 1999-01-01 |
| Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy (NCT00003622) | James Ahlgren | 1999-01-01 |
| Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer (NCT00841113) | Speciality European Pharma Limited | 1999-01-01 |
| Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer) (NCT00140374) | Cell Genesys | 1998-12-01 |
| CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy (NCT00004026) | CTI BioPharma | 1998-12-01 |
| Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors (NCT00003690) | Mayo Clinic | 1998-12-01 |
| Docetaxel in Treating Patients With Stage IV Prostate Cancer (NCT00003781) | OHSU Knight Cancer Institute | 1998-12-01 |
| Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer (NCT00003674) | Alliance for Clinical Trials in Oncology | 1998-12-01 |
| Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate (NCT00151060) | University of Michigan Rogel Cancer Center | 1998-12-01 |
| Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer (NCT00003734) | St. Luke's Hospital, Ireland | 1998-12-01 |
| Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer (NCT00003682) | UNICANCER | 1998-10-01 |
| Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer (NCT00003717) | St. Barnabas Medical Center | 1998-10-01 |
| Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy (NCT00003626) | Barbara Ann Karmanos Cancer Institute | 1998-10-01 |
| Facilitating Participation in a Prostate Cancer Risk Assessment Program (NCT02126319) | Fox Chase Cancer Center | 1998-10-01 |
| Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer (NCT00006101) | Thomas E. Ahlering | 1998-10-01 |
| Trastuzumab in Treating Patients With Prostate Cancer (NCT00003740) | Memorial Sloan Kettering Cancer Center | 1998-10-01 |
| Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research (NCT05539677) | N.N. Petrov National Medical Research Center of Oncology | 1998-09-01 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer (NCT00003400) | University of Maryland, Baltimore | 1998-09-01 |
| Brachytherapy in Treating Patients With Prostate Cancer (NCT00003312) | Radiation Therapy Oncology Group | 1998-09-01 |
| Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer (NCT00003633) | Herbert Irving Comprehensive Cancer Center | 1998-08-01 |
| Vector Delivery of the IL-12 Gene in Men With Prostate Cancer (NCT00406939) | Baylor College of Medicine | 1998-06-01 |
| Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00003391) | Weill Medical College of Cornell University | 1998-06-01 |
| Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer (NCT00003819) | Memorial Sloan Kettering Cancer Center | 1998-06-01 |
| Flavopiridol in Treating Patients With Recurrent Prostate Cancer (NCT00003256) | National Cancer Institute (NCI) | 1998-05-01 |
| Hormone Therapy in Treating Patients With Prostate Cancer (NCT00003323) | Alliance for Clinical Trials in Oncology | 1998-05-01 |
| Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer (NCT00003329) | Eastern Cooperative Oncology Group | 1998-04-07 |
| Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer (NCT00003394) | Memorial Sloan Kettering Cancer Center | 1998-04-01 |
| Diet and PSA Levels in Patients With Prostate Cancer (NCT00003367) | Memorial Sloan Kettering Cancer Center | 1998-04-01 |
| Study of Prostate Cancer in Black and White U.S. Veterans (NCT00007540) | US Department of Veterans Affairs | 1998-04-01 |
| Continuation of Follow-up of DES-Exposed Cohorts (NCT00340600) | National Cancer Institute (NCI) | 1998-03-18 |
| Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer (NCT00003343) | Pfizer | 1998-03-01 |
| Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer (NCT00003307) | University of Arizona | 1998-03-01 |
| Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer (NCT00003162) | Radiation Therapy Oncology Group | 1998-02-01 |
| Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00003238) | University of Wisconsin, Madison | 1998-02-01 |
| Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy (NCT00002874) | Radiation Therapy Oncology Group | 1998-02-01 |
| Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer (NCT00002775) | Herbert Irving Comprehensive Cancer Center | 1998-02-01 |
| To Explore Racial Differences in Potential Risk Factors for Developing Prostate Cancer in the VA Population. (NCT00007579) | US Department of Veterans Affairs | 1998-02-01 |
| Radiation Therapy in Treating Patients With Prostate Cancer (NCT00003290) | Medical Research Council | 1998-01-01 |
| I-125 Versus Pd-103 for Low Risk Prostate Cancer (NCT00494039) | VA Puget Sound Health Care System | 1998-01-01 |
| Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer (NCT00003607) | UNICANCER | 1997-12-01 |
| A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Localized Prostate Cancer (NCT00489060) | University of Calgary | 1997-12-01 |
| Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer (NCT00003084) | M.D. Anderson Cancer Center | 1997-12-01 |
| Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer (NCT00003232) | NCIC Clinical Trials Group | 1997-11-24 |
| Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21 (NCT00698711) | Memorial Sloan Kettering Cancer Center | 1997-11-01 |
| Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors (NCT00003038) | Mayo Clinic | 1997-10-01 |
| Vinorelbine in Treating Patients With Metastatic Prostate Cancer (NCT00003259) | Swiss Cancer Institute | 1997-10-01 |
| Chemotherapy in Treating Patients With Solid Tumors (NCT00003103) | Memorial Sloan Kettering Cancer Center | 1997-08-01 |
| Flavopiridol in Treating Patients With Refractory Cancer (NCT00019344) | National Cancer Institute (NCI) | 1997-08-01 |
| Problem Solving Therapy for Prostate Cancer Spousal Caregivers (NCT02085096) | University of California, San Diego | 1997-07-01 |
| Physicians' Health Study II (NCT00270647) | Brigham and Women's Hospital | 1997-07-01 |
| Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer (NCT00003104) | Memorial Sloan Kettering Cancer Center | 1997-06-01 |
| Surgery in Treating Patients With Prostate Cancer (NCT00002938) | Alliance for Clinical Trials in Oncology | 1997-05-01 |
| Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer (NCT00003124) | Herbert Irving Comprehensive Cancer Center | 1997-05-01 |
| Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer (NCT00002889) | Alliance for Clinical Trials in Oncology | 1997-05-01 |
| Hormone Therapy in Treating Patients With Advanced Prostate Cancer (NCT00003026) | European Organisation for Research and Treatment of Cancer - EORTC | 1997-04-01 |
| Group Therapy Compared With Educational Materials in Patients With Prostate Cancer (NCT00002848) | Gary Morrow | 1997-04-01 |
| Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer (NCT00003045) | Dana-Farber Cancer Institute | 1997-04-01 |
| Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00005048) | NYU Langone Health | 1997-04-01 |
| Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer (NCT00003183) | Hope Cancer Institute, Inc. | 1997-03-01 |
| Spectroscopy With Surface Coils and Decoupling (NCT00581815) | Memorial Sloan Kettering Cancer Center | 1997-02-01 |
| Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer (NCT00223665) | University of Washington | 1997-01-08 |
| Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate Cancer (NCT02091661) | University of Rome Tor Vergata | 1997-01-01 |
| PET Scan in Treating Patients With Metastatic Prostate Cancer (NCT00002981) | Memorial Sloan Kettering Cancer Center | 1997-01-01 |
| Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy (NCT00002924) | Alliance for Clinical Trials in Oncology | 1997-01-01 |
| Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer (NCT00004029) | National Cancer Institute (NCI) | 1996-12-01 |
| Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer (NCT00002881) | Eastern Cooperative Oncology Group | 1996-10-01 |
| Epidemiologic and Genetic Study on Familial Prostate Cancer (NCT01221168) | Centre de Recherche sur les Pathologies Prostatiques | 1996-10-01 |
| Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease (NCT00001503) | National Cancer Institute (NCI) | 1996-09-19 |
| Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer (NCT00002855) | M.D. Anderson Cancer Center | 1996-08-01 |
| Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer (NCT00002760) | Alliance for Clinical Trials in Oncology | 1996-08-01 |
| Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy (NCT00003115) | Roswell Park Cancer Institute | 1996-06-01 |
| Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer (NCT00003516) | Burzynski Research Institute | 1996-03-27 |
| Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer (NCT00002668) | Eastern Cooperative Oncology Group | 1996-02-14 |
| Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer (NCT00002703) | Proton Radiation Oncology Group | 1996-01-01 |
| Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer (NCT00002723) | National Cancer Institute (NCI) | 1996-01-01 |
| Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer (NCT00116220) | Dana-Farber Cancer Institute | 1995-09-01 |
| Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors (NCT00002677) | University of Maryland, Baltimore | 1995-08-01 |